C

Cigna Group
XMUN:CGN

Watchlist Manager
Cigna Group
XMUN:CGN
Watchlist
Price: 231.45 EUR -0.32% Market Closed
Market Cap: 67.7B EUR

Cigna Group
Investor Relations

Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients.

Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 30, 2025
AI Summary
Q3 2025

Strong Q3 Results: Cigna reported third quarter revenue of $69.7 billion and adjusted EPS of $7.83, both in line with expectations.

Reaffirmed 2025 Guidance: Management reiterated full year 2025 adjusted EPS guidance of at least $29.60 and expects strong capital generation.

New Pharmacy Model: Cigna announced a new rebate-free, fee-based pharmacy benefits model aimed at improving affordability and transparency, with plans to transition at least 50% of its book to this model by 2028.

Margin Pressure Ahead: Anticipated margin pressure in Pharmacy Benefit Services over the next two years due to investments in the new model and client contract renewals; operating income for the segment expected to decline in 2026.

Long-Term Growth Confidence: Despite near-term headwinds, Cigna expects EPS growth in 2026 and targets a return to its long-term growth algorithm by 2027.

Specialty and Care Strength: Specialty and Care Services delivered 11% adjusted earnings growth and are forecast to grow at the high end of long-term targets.

Resilient Healthcare Business: Cigna Healthcare segment saw solid results, with the medical care ratio at 84.8% and strong performance in the Select segment.

Key Financials
Revenue
$69.7B
Adjusted Earnings Per Share
$7.83
Evernorth Revenue
$60.4B
Evernorth Pretax Adjusted Earnings
$1.9B
Specialty and Care Services Revenue
$26.3B
Specialty and Care Services Pretax Adjusted Earnings
$928M
Pharmacy Benefit Services Revenue
$34.1B
Pharmacy Benefit Services Pretax Adjusted Earnings
$1B
Cigna Healthcare Revenue
$10.9B
Cigna Healthcare Pretax Adjusted Earnings
$1B
Medical Care Ratio
84.8%
Operating Cash Flow
$3.4B
Debt-to-Capitalization Ratio
44.9%
Pharmacy Benefit Services Client Retention
97%
Specialty Pharmacy Prescriptions Delivered
7 million prescriptions
Earnings Call Recording
Other Earnings Calls

Management

Contacts

Address
CONNECTICUT
Bloomfield
900 Cottage Grove Road
Contacts
+18602266000
www.cigna.com